My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by NeOnc Technologies Holdings, Inc.

NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health’s Perlmutter Cancer Center, to Its Scientific Advisory Board
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies to Showcase Progress on Addressing Brain Cancer to 63 Million TV Households on “Health Uncensored with Dr. Drew” on the Lifetime Network on September 25, premiering nationwide at 8:00 a.m. ET/PT
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Finalizes All Contingencies for $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Signs Definitive Agreement to Acquire AI, 3D, and Quantum Modeling IP Portfolio from Dr. Ishwar K. Puri; Appoints Him to Board of Directors
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Signs Definitive Agreement for $50 Million Strategic Partnership with Quazar Investment
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies to Participate at the BTIG Virtual Biotechnology Conference
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
CORRECTING and REPLACING - NeOnc Technologies Holdings, Inc.
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies’ Executive Chairman to Be Featured in Live Interview with Kenny Polcari on YouTube.com/@Floorstocks — Today at 11:00 a.m. ET
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Executes Sub-License Agreement, Marking Key Milestone Toward Closing $50 Million Strategic Partnership with Quazar Investment
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Secures Board Approval for $50 Million Strategic Partnership with Quazar Investment
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Holdings, Inc. Joins Russell Microcap® Index
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Holdings, Inc. Executive Chairman, Amir Heshmatpour, Assumes Expanded Leadership Role as Company’s New President
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Tickers NTHI
NeOnc Technologies Holdings Announces Effectiveness of Registration Statement and Anticipated Listing Date of Common Stock on Nasdaq Global Market
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
NEONC Technologies Holdings, Inc. Appoints Dr. Alan Chiang to its Board of Directors
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
NeOnc Technologies Appointments the Honorable Jimmy Delshad to its Board of Directors
From NeOnc Technologies Holdings, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.